Table 2. Outcome of patients by source... | American Society of Hematology

Table 2.

Outcome of patients by source and dose of nucleated cells/kg infused

	BM, %*				P
	NC less than 2.7 × 10⁸/kg	NC more than 2.7 × 10⁸/kg	PB, %*	PB vs BM less than 2.7 × 10⁸/kg	PB vs BM more than 2.7 × 10⁸/kg
2-y outcome
LFS	54 ± 3	72 ± 3	61 ± 3	.17	.04
RI	25 ± 3	14 ± 2	22 ± 3	.23	.17
TRM	27 ± 3	17 ± 2	22 ± 2	.23	.17
OS	58 ± 3	74 ± 3	66 ± 3	.08	.14
1-y cGVHD	43 ± 5	40 ± 5	50 ± 4	.002	.0006

	BM, %*				P
	NC less than 2.7 × 10⁸/kg	NC more than 2.7 × 10⁸/kg	PB, %*	PB vs BM less than 2.7 × 10⁸/kg	PB vs BM more than 2.7 × 10⁸/kg
2-y outcome
LFS	54 ± 3	72 ± 3	61 ± 3	.17	.04
RI	25 ± 3	14 ± 2	22 ± 3	.23	.17
TRM	27 ± 3	17 ± 2	22 ± 2	.23	.17
OS	58 ± 3	74 ± 3	66 ± 3	.08	.14
1-y cGVHD	43 ± 5	40 ± 5	50 ± 4	.002	.0006

Values given as mean ± SD.